Agilon Health, Inc. reported its financial results for the first quarter of 2025, revealing a total revenue of $1.53 billion, a decrease of 4% from $1.60 billion in the same period last year. The decline in revenue was primarily attributed to a 6% reduction in Medicare Advantage (MA) membership, which fell to approximately 490,700 members. Despite the revenue drop, the company achieved a net income of $12.1 million, a significant turnaround from a net loss of $6.0 million in the first quarter of 2024. This improvement was bolstered by a gain from discontinued operations related to the sale of its Hawaii operations.
In terms of expenses, Agilon's total expenses decreased to $1.55 billion from $1.61 billion year-over-year. Medical services expenses, which account for the majority of costs, also saw a reduction, falling to $1.40 billion from $1.44 billion. The company reported a gross profit of $50.7 million, down from $75.1 million in the prior year, reflecting a medical margin of $128 million compared to $157 million in the first quarter of 2024. The decrease in gross profit was influenced by the decline in membership and associated revenues.
Operationally, Agilon Health continues to focus on its strategic initiatives, including its partnerships with physician groups and the expansion of its Medicare-centric model. The company reported that it is currently managing 33 wholly-owned risk-bearing entities (RBEs) and has made significant investments in its platform to enhance service delivery. As of March 31, 2025, Agilon's cash and cash equivalents totaled $136.9 million, down from $188.2 million at the end of 2024, while marketable securities increased to $230.1 million from $211.7 million.
Looking ahead, Agilon Health anticipates ongoing challenges related to membership levels and market conditions, which may impact future revenues. The company is committed to investing in its growth strategies and expanding its geographic footprint, although it acknowledges the potential need for additional capital resources to support these initiatives. The management remains optimistic about the long-term prospects of its business model, which aims to empower primary care physicians in managing the healthcare needs of their patients.
About agilon health, inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.